Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-dimensional interstitial radiotherapy combined with gemcitabine for locally advanced pancreatic cancer
ChiCTR1800014380Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gemcitabine in pancreatic cancer (PC), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Objective response rate, Survival rate and 1 more. Planned start Mar 2018; status: not yet recruiting.
02
Drugs
gemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on ChiCTR1800014380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014380.